A carregar...

Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells

Several clinical studies have shown the beneficial effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on diabetic nephropathy. The underlying mechanisms are not fully understood. We found that administration of canagliflozin at a low dose (0.01 mg/kg/day) did not affect either blood glucos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Maki, Toshinobu, Maeno, Sayaka, Maeda, Yasutaka, Yamato, Mayumi, Sonoda, Noriyuki, Ogawa, Yoshihiro, Wakisaka, Masanori, Inoguchi, Toyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423112/
https://ncbi.nlm.nih.gov/pubmed/30886225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-41253-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!